Evidence map›Paper›PMID 38634070›Full record

ArticleIJID regions2024

Risk factors for colonization with extended-spectrum cephalosporin-resistant and carbapenem-resistant Enterobacterales among hospitalized patients in Guatemala: An Antibiotic Resistance in Communities and Hospitals (ARCH) study.

Mark A Caudell, Carmen Castillo, Lucas F Santos, Laura Grajeda, Juan Carlos Romero, Maria Renee Lopez, Sylvia Omulo, Mariangeli Freitas Ning, Guy H Palmer, Douglas R Call and 5 more

Open access · goldAbstract read
In one paragraph

Article in IJID regions, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.9field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 3 countries.

Mark A CaudellWashington State University, Paul G. Allen School for Global Health, Pullman, USA.
Carmen CastilloUniversidad del Valle de Guatemala, Center for Health Studies, Guatemala City, Guatemala.
Lucas F SantosUniversidad del Valle de Guatemala, Center for Health Studies, Guatemala City, Guatemala.
Laura GrajedaUniversidad del Valle de Guatemala, Center for Health Studies, Guatemala City, Guatemala.
Juan Carlos RomeroUniversidad del Valle de Guatemala, Center for Health Studies, Guatemala City, Guatemala.
Maria Renee LopezUniversidad del Valle de Guatemala, Center for Health Studies, Guatemala City, Guatemala.
Sylvia OmuloUniversidad del Valle de Guatemala, Center for Health Studies, Guatemala City, Guatemala.
Mariangeli Freitas NingU.S. Centers for Disease Control and Prevention, Guatemala City, Central America Regional Office, Guatemala.
Guy H PalmerWashington State University, Paul G. Allen School for Global Health, Pullman, USA.
Douglas R CallWashington State University, Paul G. Allen School for Global Health, Pullman, USA.
Celia Cordon-RosalesWashington State University, Paul G. Allen School for Global Health, Pullman, USA.
Rachel M SmithU.S. Centers for Disease Control and Prevention, Division of Healthcare Quality Promotion, Atlanta, USA.
Carolyn T A HerzigU.S. Centers for Disease Control and Prevention, Division of Healthcare Quality Promotion, Atlanta, USA.
Ashley StyczynskiU.S. Centers for Disease Control and Prevention, Division of Healthcare Quality Promotion, Atlanta, USA.
Brooke M RamayWashington State University, Paul G. Allen School for Global Health, Pullman, USA.
Universidad del Valle de Guatemala · GTWashington State University · USCenters for Disease Control and Prevention · USCenters for Disease Control and Prevention · UGWashington State Department of Health · US

Funding

ACL HHS U01GH002143CGH CDC HHS U01 GH002143
6 · The paper itself

Abstract

Objectives: The spread of extended-spectrum cephalosporin-resistant Enterobacterales (ESCrE) and carbapenem-resistant Enterobacterales (CRE) has resulted in increased morbidity, mortality, and health care costs worldwide. To identify the factors associated with ESCrE and CRE colonization within hospitals, we enrolled hospitalized patients at a regional hospital located in Guatemala. Methods: Stool samples were collected from randomly selected patients using a cross-sectional study design (March-September, 2021), and samples were tested for the presence of ESCrE and CRE. Hospital-based and household variables were examined for associations with ESCrE and CRE colonization using lasso regression models, clustered by ward (n = 21). Results: A total of 641 patients were enrolled, of whom complete data sets were available for 593. Colonization with ESCrE (72.3%, n = 429/593) was negatively associated with carbapenem administration (odds ratio [OR] 0.21, 95% confidence interval [CI] 0.11-0.42) and positively associated with ceftriaxone administration (OR 1.61, 95% CI 1.02-2.53), as was reported hospital admission within 30 days of the current hospitalization (OR 2.84, 95% CI 1.19-6.80). Colonization with CRE (34.6%, n = 205 of 593) was associated with carbapenem administration (OR 2.62, 95% CI 1.39-4.97), reported previous hospital admission within 30 days of current hospitalization (OR 2.58, 95% CI 1.17-5.72), hospitalization in wards with more patients (OR 1.05, 95% CI 1.02-1.08), hospitalization for ≥4 days (OR 3.07, 95% CI 1.72-5.46), and intubation (OR 2.51, 95% CI 1.13-5.59). No household-based variables were associated with ESCrE or CRE colonization in hospitalized patients. Conclusion: The hospital-based risk factors identified in this study are similar to what has been reported for risk of health care-associated infections, consistent with colonization being driven by hospital settings rather than community factors. This also suggests that colonization with ESCrE and CRE could be a useful metric to evaluate the efficacy of infection and prevention control programs in clinics and hospitals.

Indexed as

Antimicrobial resistanceColonizationGuatemalaHospitals

Identifiers

PMID38634070
PMCPMC11021947
OpenAlexW4393340093

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.